Yair Fisher
Directeur Technique/Scientifique/R&D chez Glixogen Therapeutics Ltd.
Postes actifs de Yair Fisher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Directeur Technique/Scientifique/R&D | 01/12/2018 | - |
| Directeur Général | 01/12/2018 | - |
Historique de carrière de Yair Fisher
Formation de Yair Fisher
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistiques
Internationale
| Israël | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
- Bourse
- Insiders
- Yair Fisher
- Expérience
